Davide Paganoni

Davide Paganoni currently serves as Global Franchise Lead for Oncology and Haematology at Recordati Rare Diseases, where responsibilities include driving global strategies and managing cross-functional teams following the acquisition of EUSA Pharma. Prior roles include VP and General Manager at EUSA Pharma, managing business operations in Southern Europe, and General Manager positions at Exeltis Italia and Amryt Pharma, focusing on innovative treatments for rare diseases. Extensive experience includes senior leadership roles at Alexion Pharmaceuticals and HJ Heinz, contributing to business and marketing strategy development. Davide holds a degree in Biology, eco-toxicology from Università degli Studi di Milano.